Breaking News Instant updates and real-time market news.

ATNX

Athenex

$17.20

-0.08 (-0.46%)

08:12
04/19/18
04/19
08:12
04/19/18
08:12

Athenex receives FDA Orphan Drug Designation for Oraxol

Athenex announced that it has received Orphan Drug Designation from the U.S. FDA for Oraxol for the treatment of angiosarcoma. Oraxol, an innovative development in the treatment of cancer, is a novel oral formulation of paclitaxel, a very effective and commonly used chemotherapy treatment for many cancers, combined with HM30181A.

  • 08

    May

  • 21

    May

ATNX Athenex
$17.20

-0.08 (-0.46%)

09/18/17
FBCO
09/18/17
INITIATION
Target $25
FBCO
Outperform
Athenex initiated with an Outperform at Credit Suisse
Credit Suisse analyst Iris Wang started Athenex with an Outperform rating and $25 price target. The company's pipeline of orally delivered chemotherapeutic agents offers an attractive risk-reward profile, Wang tells investors in a research note titled "An emerging biotech unicorn."
09/18/17
09/18/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Teck Resources (TECK) initiated with a Sell at Axiom. 2. GenMark (GNMK) initiated with a Buy at BofA/Merrill. 3. Cirrus Logic (CRUS) initiated with an Underperform at BofA/Merrill. 4. Athenex (ATNX) initiated with an Outperform at Credit Suisse. 5. Brookfield Infrastructure (BIP) reinitiated with a Neutral at Credit Suisse. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
01/17/18
DBAB
01/17/18
NO CHANGE
Target $20
DBAB
Buy
Athenex feedback from FDA removes key overhang, says Deutsche Bank
The positive FDA feedback, where Athenex and the agency agreed on an ongoing Phase 3 study as a registration study, effectively removed a key regulatory overhang of the stock, Deutsche Bank analyst Jack Hu tells investors in a research note. The analyst had been concerned that FDA might not approve Oraxol even if the trial turns out to be successful. He now believes, however, that the Phase 3 study has "much reduced" regulatory risks. The analyst keeps a Buy rating on Athenex with a $20 price target.
03/06/18
NEED
03/06/18
INITIATION
Target $30
NEED
Buy
Athenex initiated with a Buy at Needham
Needham analyst Chad Messer initiated Athenex with a Buy rating and a price target of $30, saying the company is evolving into a global pharma entity with both API and commercial product manufacturing development. Messer sees its Orascovery platform as a key value driver, potentially "enabling oral delivery of traditionally I.V. forms of chemotherapy" which is not only more convenient and cost effective but also reduces the high peak and low trough drug concentrations inherent in I.V. delivery.

TODAY'S FREE FLY STORIES

AZO

AutoZone

$732.74

-14.79 (-1.98%)

, AAP

Advance Auto Parts

$167.64

4.25 (2.60%)

08:54
09/19/18
09/19
08:54
09/19/18
08:54
Recommendations
AutoZone, Advance Auto Parts, O'Reilly Automotive analyst commentary  »

AutoZone price target…

AZO

AutoZone

$732.74

-14.79 (-1.98%)

AAP

Advance Auto Parts

$167.64

4.25 (2.60%)

ORLY

O'Reilly Automotive

$340.65

3.98 (1.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

TLRY

Tilray

$154.99

34.79 (28.94%)

08:53
09/19/18
09/19
08:53
09/19/18
08:53
Hot Stocks
Citron says still short Tilray, recent rally 'beyond comprehension' »

Short-seller Citron…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TROW

T. Rowe Price

$109.29

0.3 (0.28%)

08:53
09/19/18
09/19
08:53
09/19/18
08:53
Conference/Events
T. Rowe Price management to meet with William Blair »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

08:53
09/19/18
09/19
08:53
09/19/18
08:53
Conference/Events
Roth Capital to hold a conference »

4th Annual Datacenter…

08:50
09/19/18
09/19
08:50
09/19/18
08:50
Conference/Events
Canaccord to hold a conference »

Artificial Intelligence…

08:50
09/19/18
09/19
08:50
09/19/18
08:50
General news
U.S. Q2 current account deficit narrowed to -$101.5 B »

U.S. Q2 current account…

08:50
09/19/18
09/19
08:50
09/19/18
08:50
General news
Treasury Action: yields drifted below highs »

Treasury Action: yields…

HEAR

Turtle Beach

$17.75

-1.55 (-8.03%)

08:49
09/19/18
09/19
08:49
09/19/18
08:49
Recommendations
Turtle Beach analyst commentary  »

Turtle Beach 45% pullback…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEA

Lear

$154.96

-2.2 (-1.40%)

08:47
09/19/18
09/19
08:47
09/19/18
08:47
Recommendations
Lear analyst commentary  »

Lear price target lowered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

TNDM

TNDM

08:47
09/19/18
09/19
08:47
09/19/18
08:47
Conference/Events
Tandem Diabetes management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 21

    Sep

  • 25

    Sep

  • 27

    Nov

GWPH

GW Pharmaceuticals

$149.14

8.165 (5.79%)

08:47
09/19/18
09/19
08:47
09/19/18
08:47
Recommendations
GW Pharmaceuticals analyst commentary  »

Launch of GW…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

TFX

Teleflex

$269.03

1.81 (0.68%)

08:46
09/19/18
09/19
08:46
09/19/18
08:46
Conference/Events
Teleflex management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 21

    Sep

  • 09

    Oct

NVS

Novartis

$85.03

-0.1 (-0.12%)

08:46
09/19/18
09/19
08:46
09/19/18
08:46
Conference/Events
Novartis has a conference call hosted by JPMorgan »

JPMorgan Analyst Vosser …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 20

    Sep

SPWH

Sportsman's Warehouse

$6.15

-0.02 (-0.32%)

08:45
09/19/18
09/19
08:45
09/19/18
08:45
Conference/Events
Sportsman's Warehouse management to meet with MKM Partners »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

08:45
09/19/18
09/19
08:45
09/19/18
08:45
General news
U.S. housing starts rose 9.2% to 1.282 M in August »

U.S. housing starts rose…

SSC

Seven Stars Cloud Group

$4.38

-0.3 (-6.41%)

, CBL

CBL & Associates

$4.34

0.005 (0.12%)

08:45
09/19/18
09/19
08:45
09/19/18
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

SSC

Seven Stars Cloud Group

$4.38

-0.3 (-6.41%)

CBL

CBL & Associates

$4.34

0.005 (0.12%)

MELI

MercadoLibre

$315.06

-7.02 (-2.18%)

SQQQ

ProShares UltraPro Short QQQ

$11.80

-0.3 (-2.48%)

GERN

Geron

$5.48

0.05 (0.92%)

KEY

KeyCorp

$19.74

-0.11 (-0.55%)

CGC

Canopy Growth

$51.77

3.25 (6.70%)

SGYP

Synergy Pharmaceuticals

$1.69

0.005 (0.30%)

SDS

UltraShort S&P500 ProShares

$33.45

-0.41 (-1.21%)

AMJ

American Medical Laboratories Inc

$27.87

0.04 (0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 01

    Oct

  • 13

    Oct

  • 18

    Oct

  • 30

    Oct

  • 30

    Oct

08:45
09/19/18
09/19
08:45
09/19/18
08:45
General news
FX Action: The dollar »

FX Action: The dollar was…

08:45
09/19/18
09/19
08:45
09/19/18
08:45
General news
U.S. Q2 current account deficit narrowed to -$101.5 B »

U.S. Q2 current account…

ATHN

Athenahealth

$135.25

-8.005 (-5.59%)

08:43
09/19/18
09/19
08:43
09/19/18
08:43
Recommendations
Athenahealth analyst commentary  »

Leerink sees risk of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEIC

SEI Investments

$62.66

0.26 (0.42%)

08:42
09/19/18
09/19
08:42
09/19/18
08:42
Conference/Events
SEI Investments management to meet with Oppeheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

08:40
09/19/18
09/19
08:40
09/19/18
08:40
Conference/Events
The Atlanta Society of Finance & Investment Professionals to hold a meeting »

The Atlanta Society of…

OCFC

OceanFirst Financial

$28.39

-0.16 (-0.56%)

, SBBX

SB One Bancorp

$26.10

-0.5 (-1.88%)

08:39
09/19/18
09/19
08:39
09/19/18
08:39
Conference/Events
DA Davidson to hold a conference »

The Mid-Atlantic…

OCFC

OceanFirst Financial

$28.39

-0.16 (-0.56%)

SBBX

SB One Bancorp

$26.10

-0.5 (-1.88%)

WSFS

WSFS Financial

$47.93

-0.475 (-0.98%)

MBCN

Middlefield Banc

$47.35

-1.15 (-2.37%)

FFDF

FFD Financial

$0.00

(0.00%)

WSBC

WesBanco

$45.70

-0.74 (-1.59%)

EMCF

Emclaire Financial

$37.00

-0.45 (-1.20%)

TSC

TriState Capital

$28.40

-0.25 (-0.87%)

STBA

S&T Bancorp

$45.27

(0.00%)

SMMF

Summit Financial Group

$24.75

0.39 (1.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 24

    Sep

  • 23

    Oct

CSII

Cardiovascular Systems

$38.05

0.47 (1.25%)

08:39
09/19/18
09/19
08:39
09/19/18
08:39
Recommendations
Cardiovascular Systems analyst commentary  »

Cardiovascular Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

AMRX

Amneal Pharmaceuticals

$23.46

0.62 (2.71%)

, JAZZ

Jazz Pharmaceuticals

$161.89

0.92 (0.57%)

08:38
09/19/18
09/19
08:38
09/19/18
08:38
Recommendations
Amneal Pharmaceuticals, Jazz Pharmaceuticals, Mylan, Amgen, Teva analyst commentary  »

Leerink…

AMRX

Amneal Pharmaceuticals

$23.46

0.62 (2.71%)

JAZZ

Jazz Pharmaceuticals

$161.89

0.92 (0.57%)

MYL

Mylan

$37.80

0.59 (1.59%)

AMGN

Amgen

$202.32

1.5 (0.75%)

TEVA

Teva

$24.50

1.06 (4.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 01

    Oct

  • 17

    Oct

  • 22

    Oct

  • 27

    Oct

  • 09

    Nov

  • 13

    Nov

  • 27

    Nov

  • 20

    Dec

MGRC

McGrath RentCorp

$52.86

-0.15 (-0.28%)

08:37
09/19/18
09/19
08:37
09/19/18
08:37
Initiation
McGrath RentCorp initiated  »

McGrath RentCorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.